Armata Pharmaceuticals Q3 EPS $(0.86) Misses $(0.31) Estimate, Sales $1.23M Beat $950.00K Estimate
Armata Pharmaceuticals Q3 EPS $(0.86) Misses $(0.31) Estimate, Sales $1.23M Beat $950.00K Estimate
Armata Pharmicals第三季度每股收益（0.86美元）未達到預期（0.31美元），銷售額123萬美元超過預期的9.5萬美元
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.31) by 177.42 percent. This is a 258.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.23 million which beat the analyst consensus estimate of $950.00 thousand by 28.95 percent. This is a 8.45 percent decrease over sales of $1.34 million the same period last year.
Armata Pharmicals（AMEX: ARMP）公佈季度每股虧損0.86美元，比分析師共識估計的0.31美元（0.31美元）低177.42％。這比去年同期每股虧損0.24美元（0.24美元）下降了258.33％。該公司公佈的季度銷售額爲123萬美元，比分析師普遍估計的95萬美元高出28.95％。這比去年同期的134萬美元銷售額下降了8.45％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。